OXIS - Must Read News - Oxis Biotech, Inc. executed definitive agreements licensing certain assets for the treatment of Multiple Myeloma and initiated a consulting agreement with University of Pittsburgh's Professor, Dr. Xiang-Qun(Sean)Xie -
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U